Novo Nordisk's diabetes pill Rybelsus to be covered by Express Scripts

Send a link to a friend  Share

[January 17, 2020]  COPENHAGEN (Reuters) - Novo Nordisk's new diabetes pill, Rybelsus, will be covered by Express Scripts Holding Co, one of the largest U.S. pharmacy benefit managers, the Danish drugmaker said on Friday.

Pharmacy benefit managers act as middlemen in the drug supply chain, and negotiate discounts on drugs on behalf of health insurers.

Depending on the discounts drugmakers are willing to provide, pharmacy benefits managers make decisions about which drugs to include in coverage plans.

Novo Nordisk declined to comment on what discounts it had offered.

The news, first reported by Danish daily Børsen on Friday, was confirmed to Reuters by a Novo Nordisk spokesman.

(Reporting by Stine Jacobsen; editing by Muralikumar Anantharaman and Jason Neely)

[to top of second column]

 

[© 2020 Thomson Reuters. All rights reserved.]

Copyright 2020 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.

 

Back to top